Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05657665
Other study ID # ICBE-S-000880
Secondary ID
Status Completed
Phase
First received
Last updated
Start date February 6, 2023
Est. completion date April 11, 2023

Study information

Verified date April 2023
Source Philips Electronics Nederland B.V. acting through Philips CTO organization
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The primary objective is to gather missing information in order to form a well-founded recommendation on which is the preferred skin pigmentation measurement (PPM) methods in the context of pulse-oximetry.


Description:

Skin tone bias in pulse-oximetry (SpO2) needs to be addressed urgently. While skin pigmentation is a prime candidate for the root cause of skin tone bias in SpO2, more research is needed. F A solid comparison and recommendation requires evaluation of several additional aspects that affect accuracy, precision, and reproducibility of the PMMs. Briefly, these additional aspects that are evaluated in this study are listed below: - operator bias - impact of operator color blindness - probe pressure - probe aperture size - device stability - impact of blood on pigmentation measurement - feasibility of skin tone measurement on sides of fingers - intra-operator variability PMMs included in this study are: Subjective color matching methods by using: 1. Von Luschan color scale 2. Fitzpatrick color scale 3. Pantone color scale Objective probe-based measurements by using: 1. Konica Minolta CM700d (reflectance spectrometer) 2. Mx18 (erythema-melanin meter) 3. SPA99 (erythema-melanin meter) Measurements will be performed on 5 relatively light skinned, and 5 relatively dark skinned volunteers (N=10 in total*). The study will be executed on the High-Tech Campus Eindhoven (Netherlands) and each participant will have 3 visits of approximately 1.5 to 2 hours/visit.


Recruitment information / eligibility

Status Completed
Enrollment 12
Est. completion date April 11, 2023
Est. primary completion date April 11, 2023
Accepts healthy volunteers
Gender All
Age group 18 Years to 66 Years
Eligibility Inclusion Criteria: 1. Adults (18-65 years) 2. Fluent in either English or Dutch 3. Participants who are willing and able to provide informed consent themselves. 4. People with Von Luschan scores <18 ('light skin' group) or > 25 ('dark skin' group). Exclusion Criteria: 1. Skin conditions that could potentially interfere with the measurements: - piercings/ink/henna tattoos that cover the left forearm, hands, fingers or forehead - vascular or pigmentary or renal psoriasis - epidermal bullosum - other diseases that affect the skin (tone) of the body 2. COVID-19 exclusion criteria*: - Currently displaying COVID-19-related symptoms, namely a fever, cough and/or difficulty breathing - Having been positively tested as infected with COVID-19 in the past 14 days - Travelled to or from high risk COVID-19 areas in the past 14 days - Been in contact with a (suspected) COVID-infected person in the past 14 days 3. Not being able to travel to Eindhoven 3 times, and/or not being able to comply with the study procedures 4. Sunbathing during the study duration or substantial sun exposure (due to holidays for example). 5. Known allergic reaction to facial make-up 6. Usage of tanning sprays/cremes 7. Wearing make-up during the study visits (mascara is allowed) - No testing will be performed in the study. Participants will be asked if they have been positively tested.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Observational measurements of skin tone
Objective and subjective skin tone measurements will be performed.

Locations

Country Name City State
Netherlands High Tech Campus Eindhoven

Sponsors (1)

Lead Sponsor Collaborator
Philips Electronics Nederland B.V. acting through Philips CTO organization

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Preferred skin PMM in the context of pulse-oximetry. The primary objective is to complement a previous skin pigmentation study executed by Philips to gather missing information in order to form a well-founded recommendation on which is the preferred skin PPM in the context of pulse-oximetry. 10 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT02846974 - Calibration and Validation of High Quality Low-Cost 3D Printed Pulse Oximeter
Completed NCT03383757 - U-TruSignal SpO2 Testing in Neonates N/A
Recruiting NCT04233827 - Mobile Biosensor for Measuring Vital Signs in Healthcare and Home Settings
Completed NCT02987985 - Efficacy of Opioid-free Anesthesia in Reducing Postoperative Respiratory Depression in Children Undergoing Tonsillectomy Phase 3
Completed NCT05185427 - Pulse Oximetry and Skin Pigmentation - Peds
Terminated NCT03843489 - SpO2 Accuracy In Vivo Testing for Neonates & Infants N/A
Recruiting NCT06298422 - Oxygen Saturations Across Tones of Skin
Completed NCT01472133 - Validation of Respiration Rate Algorithms N/A
Completed NCT01613222 - SpO2 System Accuracy Testing With Different Sensors N/A
Enrolling by invitation NCT05681637 - SpO2 Difference Between Fingers of the Hand During Sequential Desaturation and Step Resaturation N/A
Enrolling by invitation NCT05657288 - SpO2 Comparison Between Commercial Smartwatch and Medical-grade Pulse Oximeter During Hypoxia N/A
Not yet recruiting NCT05994417 - Beyond Race: Objectively Assessed Skin Color and Its Association With Pulse Oximeter Bias in Critically Ill Infants
Recruiting NCT05554510 - Pulse Oximetry Errors in Hospitalized Patients Across Varying Skin Pigmentation
Recruiting NCT06063148 - Neonatal Pulse Oximetry Disparities Due to Skin Pigmentation N/A